NAVIFY® Infection Management*

Powered by Innovaccer

Announcing the development of a new product that will help redefine the management of acute infections.


NAVIFY Infection Management* is being designed to enable timely and optimal therapy based on guidelines for patients with serious infections. The solution helps streamline workflows, provides contextualized insights and supports analytics to track key metrics.

NAVIFY Infection Management*

Powered by Innovaccer

Announcing the development of a new product that will help redefine the management of acute infections


NAVIFY Infection Management* is being designed to enable timely and optimal therapy based on guidelines for patients with serious infections. The solution helps streamline workflows, provides contextualized insights and supports analytics to track key metrics.

COVID-19 and

NAVIFY Infection Management*

Powered by Innovaccer


In the wake of the COVID-19 pandemic, acute infections have contributed to increasing healthcare burdens.  These include higher rates of hospitalization, length-of-stay and readmission.

With our shared, deep understanding of clinical science and medical care, Roche is developing NAVIFY Infection Management* with the goal of helping to improve patient care by capturing opportunities that lie in integrating and activating healthcare data to support more efficient care delivery.

NAVIFY Infection Management and Innovaccer Health Cloud

Antimicrobial stewardship

Bringing insights closer to the bedside*

Infections have a significant effect on quality of care impacting accreditation, CMS Quality Star ratings and other quality and safety rankings, as well as HEDIS measures.  In addition to improved CMS start ratings and compliance to CMS CoP rules, TJC accreditation, and increased value-based payments, data from external studies show the value of effective stewardship programs include:

ASP team, Care team, Admin on patient prioritization

stats on NAVIFY Infection Management and Innovaccer's Antimicrobial Stewardship

1https://aricjournal.biomedcentral.com/articles/10.1186/s13756-019-0471-0
* Product in development and not commercially available